| HQL-79 |
| 4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl-piperidine |
| (CAS 162641-16-9) |
 |
| Description： |
HQL-79 is a selective inhibitor of hematopoietic prostaglandin D (PGD) synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine. Subsequent evaluation in models of allergy and asthma demonstrates the HQL-79 is orally available, and inhibits the synthesis of PGD2. HQL-79 is thus a likely lead compound for the preparation of potent, selective hematopoietic PGD synthase inhibitors.
|
| Product No. |
KT00431 |
| Product Name |
HQL-79 |
| Synonyms |
|
| Formal Name |
4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl-piperidine |
| CAS Number |
162641-16-9 |
| Molecular Formula |
C22H27N5O |
| Formula Weight |
377.5 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Hematopoietic-PGDS Inhibitor Screening Kit
Prostaglandin D2
Prostaglandin D2-MOX EIA Kit
Prostaglandin D2-MOX Express EIA Kit
Prostaglandin D Synthase (hematopoietic-type) Polyclonal Antibody
Prostaglandin D Synthase (lipocalin-type) Polyclonal Antibody
Prostaglandin E2 Express EIA Kit
|
|
